Lipoxin A4

Lipoxin a4 is a lipid of Fatty Acyls (FA) class. Lipoxin a4 is associated with abnormalities such as Asthma, Cystic Fibrosis, Pneumonia, Obesity and Septicemia. The involved functions are known as Inflammation, Signal, Signal Transduction, Regulation and Metabolic Inhibition. Lipoxin a4 often locates in Immune system, Blood, soluble, Extracellular and Splenic Tissue. The associated genes with Lipoxin A4 are FPR2 gene, Homologous Gene, SAA1 gene, Trp-Lys-Tyr-Met-Val-Met and Annexin 1. The related lipids are Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Lipoxin A4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Lipoxin A4?

Lipoxin A4 is suspected in Asthma, Cystic Fibrosis, Chagas Cardiomyopathy, Pneumonia, Obesity, Septicemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Lipoxin A4

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lung Diseases D008171 37 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Osteitis D010000 10 associated lipids
Substance Withdrawal Syndrome D013375 9 associated lipids
Asthma D001249 52 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Endometriosis D004715 29 associated lipids
Peritonitis D010538 38 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Hyperplasia D006965 34 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Fibrosis D005355 23 associated lipids
Glomerulonephritis D005921 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Nasal Polyps D009298 26 associated lipids
Hyperalgesia D006930 42 associated lipids
Toxoplasmosis D014123 9 associated lipids
Eosinophilia D004802 4 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Catalepsy D002375 30 associated lipids
Acute-Phase Reaction D000210 12 associated lipids
Disease Susceptibility D004198 12 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Uveitis D014605 14 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Klebsiella Infections D007710 7 associated lipids
Carotid Stenosis D016893 15 associated lipids
Toxoplasmosis, Animal D014124 5 associated lipids
Atherosclerosis D050197 85 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Insulin Resistance D007333 99 associated lipids
Encephalitis D004660 15 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Acute Lung Injury D055371 33 associated lipids
Neuralgia D009437 28 associated lipids
Gastroenteritis D005759 4 associated lipids
Peritoneal Diseases D010532 6 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Tendon Injuries D013708 4 associated lipids
Per page 10 20 50 100 | Total 53

PubChem Associated disorders and diseases

What pathways are associated with Lipoxin A4

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Lipoxin A4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Lipoxin A4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Lipoxin A4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Lipoxin A4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Lipoxin A4?

Knock-out

Knock-out are used in the study 'Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.' (Ortiz-Muñoz G et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Lipoxin A4

Download all related citations
Per page 10 20 50 100 | Total 639
Authors Title Published Journal PubMed Link
DoÄŸan B et al. Lipoxin A4 and Neutrophil/Lymphocyte Ratio: A Possible Indicator in Achieved Systemic Risk Factors for Periodontitis. 2015 Med. Sci. Monit. pmid:26298769
Lehmann C et al. Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein. 2015 FASEB J. pmid:26289316
Roach KM et al. Lipoxin A4 Attenuates Constitutive and TGF-β1-Dependent Profibrotic Activity in Human Lung Myofibroblasts. 2015 J. Immunol. pmid:26276873
Sha YH et al. Lipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXRα signaling pathway in THP-1 macrophage-derived foam cells. 2015 Int J Clin Exp Pathol pmid:26261553
Yuan ZX and Rapoport SI Transient postnatal fluoxetine decreases brain concentrations of 20-HETE and 15-epi-LXA4, arachidonic acid metabolites in adult mice. 2015 Prostaglandins Leukot. Essent. Fatty Acids pmid:26234927
Herrera BS et al. LXA4 actions direct fibroblast function and wound closure. 2015 Biochem. Biophys. Res. Commun. pmid:26188508
Fang X et al. Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4. 2015 J. Immunol. pmid:26116507
Ramirez JL et al. A mosquito lipoxin/lipocalin complex mediates innate immune priming in Anopheles gambiae. 2015 Nat Commun pmid:26100162
Awji EG et al. Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells. 2015 Am. J. Respir. Cell Mol. Biol. pmid:25137396
Dunn HC et al. Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model. 2015 J. Alzheimers Dis. pmid:25125468
Meng F et al. Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation. 2015 Am. J. Respir. Cell Mol. Biol. pmid:24992633
Wenceslau CF et al. Lipoxin A4 mediates aortic contraction via RHOA/RHO kinase, endothelial dysfunction and reactive oxygen species. 2014 J. Vasc. Res. pmid:25612650
Polavarapu S et al. Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro. 2014 PLoS ONE pmid:25536345
Zimring JC The fat and the skinny on acute lung injury. 2014 Blood pmid:25342661
Martini AC et al. Neuroprotective effects of lipoxin A4 in central nervous system pathologies. 2014 Biomed Res Int pmid:25276776
Esquivias P et al. Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model. 2014 Oncol. Rep. pmid:24737143
Yang F et al. Regional arterial infusion with lipoxin A4 attenuates experimental severe acute pancreatitis. 2014 PLoS ONE pmid:25265022
Ono E et al. Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. 2014 Am. J. Respir. Crit. Care Med. pmid:25162465
Ortiz-Muñoz G et al. Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. 2014 Blood pmid:25143486
Andersson P et al. Inhibition of neutrophil-dependent cytotoxicity for human endothelial cells by ACE inhibitors. 2014 Scand. J. Immunol. pmid:25124788
Wu R et al. Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway. 2014 Br. J. Pharmacol. pmid:24923883
Zhou XL et al. Protective effects of lipoxin A4 in testis injury following testicular torsion and detorsion in rats. 2014 Mediators Inflamm. pmid:24904198
Martin CR et al. Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. 2014 PLoS ONE pmid:24892762
Tani Y et al. Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice. 2014 FASEB J. pmid:24891522
Wu H et al. Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice. 2014 PLoS ONE pmid:24671173
Kumar R et al. Lipoxin Aâ‚„ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin Eâ‚‚ production and estrogen signaling. 2014 PLoS ONE pmid:24587003
Zhao Q et al. LipoxinA4 attenuates myocardial ischemia reperfusion injury via a mechanism related to downregulation of GRP-78 and caspase-12 in rats. 2014 Heart Vessels pmid:24129401
Yao C et al. Aspirin-triggered lipoxin A4 attenuates lipopolysaccharide induced inflammatory response in primary astrocytes. 2014 Int. Immunopharmacol. pmid:24269179
Ramon S et al. Lipoxin Aâ‚„ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism. 2014 Eur. J. Immunol. pmid:24166736
Xu Z et al. Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator. 2014 Fertil. Steril. pmid:24796762
Chen S et al. Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17β-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells. 2014 Fertil. Steril. pmid:24835059
Nanhwan MK et al. Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect. 2014 Arterioscler. Thromb. Vasc. Biol. pmid:25012137
Li C et al. Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. 2014 J. Exp. Med. pmid:24395886
Ballesteros I et al. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways. 2014 J. Leukoc. Biol. pmid:24338629
Eke Gungor H et al. Decreased levels of lipoxin A4 and annexin A1 in wheezy infants. 2014 Int. Arch. Allergy Immunol. pmid:24525704
Osuchowski MF Tender mediation in a ruthless environment: can lipoxins provide lifesaving modifications to fatally deregulated immunoinflammatory responses in sepsis?*. 2014 Crit. Care Med. pmid:24633114
Leo LM et al. Age-dependent relevance of endogenous 5-lipoxygenase derivatives in anxiety-like behavior in mice. 2014 PLoS ONE pmid:24416334
Hamza B et al. Retrotaxis of human neutrophils during mechanical confinement inside microfluidic channels. 2014 Integr Biol (Camb) pmid:24419464
Ueda T et al. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*. 2014 Crit. Care Med. pmid:24463858
Higgins G et al. Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis. 2014 Am. J. Respir. Cell Mol. Biol. pmid:24588705
Zhang D et al. Glucocorticoids sensitize rat placental inflammatory responses via inhibiting lipoxin A4 biosynthesis. 2014 Biol. Reprod. pmid:24571985
Tateishi N et al. Dietary supplementation of arachidonic acid increases arachidonic acid and lipoxin Aâ‚„ contents in colon, but does not affect severity or prostaglandin Eâ‚‚ content in murine colitis model. 2014 Lipids Health Dis pmid:24507383
Fischer CD et al. Tulathromycin exerts proresolving effects in bovine neutrophils by inhibiting phospholipases and altering leukotriene B4, prostaglandin E2, and lipoxin A4 production. 2014 Antimicrob. Agents Chemother. pmid:24820086
Ringholz FC et al. Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis. 2014 Eur. Respir. J. pmid:24696116
Chen XQ et al. Involvement of K+ channel-dependant pathways in lipoxin A4-induced protective effects on hypoxia/reoxygenation injury of cardiomyocytes. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:23602847
Planagumà A et al. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function. 2013 Clin. Exp. Immunol. pmid:23607720
Shryock N et al. Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain. 2013 PLoS ONE pmid:23613965
Hanson J et al. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin Aâ‚„. 2013 Biochem. Pharmacol. pmid:23643932
Medeiros R et al. Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice. 2013 Am. J. Pathol. pmid:23506847
Xu Z et al. Spontaneous miscarriages are explained by the stress/glucocorticoid/lipoxin A4 axis. 2013 J. Immunol. pmid:23677469